Dr. Sanjiva Bimal
Scientist
Rajendra Memorial Research Institute of Medical Science
Indian Council of Medical Research
India
Biography
Educational Qualifications: Dec -1998 Ph.D. Zoology, Division of Parasitology, Centreal Drug Research Institute, Lucknow, India and Div. of Immunology, RMRIMS, Patna from BRA Bihar University, Muzaffarpur, India 1983 - M.Sc. Zoology, 2nd Rank in university, Division of Zoology, BRA Bihar University, Muzaffarpur, India 1979 - B.Sc. Hons(Zoology Hons), L.S. College, BRA Bihar University, Muzaffarpur Research Experience: Immunology, Structure and function of proteins, Microbiology Imuno-suppression, Drug resistance, Diagnosticts, Vaccine Post Organization Period Lecturer( Zoology) KCTC College, Raxaul, India 1984-1985 Research Assistant Rajendra Memorial Research Institute of Medical Sciences (ICMR), Patna-800007, India 25.09.1985- 13.03.2000 Scientist B Rajendra Memorial Research Institute of Medical Sciences (ICMR), Patna-800007, India 14.03.2000-13.03.2005 Scientist C Rajendra Memorial Research Institute of Medical Sciences (ICMR), Patna-800007, India 14.03.2005-31.08-2010 Scientist D Rajendra Memorial Research Institute of Medical Sciences (ICMR), Patna-800007, India 01.09.2010-31.08-2014 Scientist E Rajendra Memorial Research Institute of Medical Sciences (ICMR), Patna-800007, India 01.09.2014-Till Date
Research Interest
Immunology
Publications
-
Pandey K, Pal B, Das VN, Murti K, Lal CS, Verma N, Bimal S, Ali V, Verma RB, Topno RK, Siddiqi NA and Das P. Safety and efficacy of a combination of Paromomycin and Miltefosine for two versus three courses in patients with Post Kala-Azar Dermal Leishmaniasis (PKDL) - an observational pilot Study. Br J Dermatol. 2017; 177(2):557-559.
-
Shivam P, Kumari S, Jamal F, Kumar V, Kumar M, Bimal S, Narayan S, Das VNR, Pandey K, Gupta AK, Das P and Singh SK. Leishmania donovani resistant to Ambisome or Miltefosine exacerbates CD58 expression on NK cells and promotes trans-membrane migration in association with CD2. Cytokine. 2017; 96:54-58.
-
Dikhit MR, Amit A, Singh AK, Kumar A, Mansuri R, Sinha S, Topno RK, Mishra R, Das VNR, Pandey K, Sahoo GC, Ali V, Bimal S and Das P. Vaccine potential of HLA-A2 epitopes from Leishmania Cysteine Protease Type III (CPC). Parasite Immunol. 2017 Sep;39(9).
